Rchr
J-GLOBAL ID:202201007572500050
Update date: Feb. 01, 2024
MORI YASUO
モリ ヤスオ | MORI YASUO
Affiliation and department:
Research theme for competitive and other funds (7):
- 2021 - 2024 崩壊した口腔常在微生物叢を占有する外来性定着種の網羅的特定と予後への影響の解明
- 2021 - 2024 臨床応用に向けたヒト白血病幹細胞特異的標的分子TIM-3の機能解明
- 2020 - 2023 CD35陽性白血病幹細胞の機能解析と治療標的候補分子の抽出
- 2017 - 2020 Exhaustive fractionation of human HSCs by high-sensitive single cell analysis
- 2014 - 2016 Identification of neutrophil lineage-committed progenitors and their developmental mechanism
- 2010 - 2012 ヒト顆粒球系造血前駆細胞を標的とした慢性アレルギー・炎症性疾患の新たな治療戦略
- 2010 - 2010 ヒト顆粒球系造血前駆細胞を標的とした慢性アレルギー・炎症性疾患の新たな治療戦略
Show all
Papers (70):
-
Shiho Taniguchi, Sae Utsumi, Yu Kochi, Yuki Taya, Yasuo Mori, Yu-ichiro Semba, Takeshi Sugio, Kohta Miyawaki, Yoshikane Kikushige, Yuya Kunisaki, et al. Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation. International Journal of Hematology. 2022
-
Takaaki Konuma, Shohei Mizuno, Kaito Harada, Naoyuki Uchida, Satoshi Takahashi, Tetsuya Eto, Shuichi Ota, Hikaru Kobayashi, Yuta Katayama, Yasuo Mori, et al. Reducing mortality of single-unit unrelated cord blood transplantation for relapsed acute myeloid leukemia after a previous allogeneic transplantation: a real-world retrospective study over the past 19 years in Japan. Transplantation and cellular therapy. 2022. 28. 11. 777.e1-777.e11
-
Yasuo Mori, Takuya Harada, Goichi Yoshimoto, Takahiro Shima, Akihiko Numata, Fumiaki Jinnouchi, Takuji Yamauchi, Yoshikane Kikushige, Yuya Kunisaki, Koji Kato, et al. Risk factors for late cytomegalovirus infection after completing letermovir prophylaxis. International journal of hematology. 2022. 116. 2. 258-265
-
Yoshinobu Kanda, Noriko Doki, Minoru Kojima, Shinichi Kako, Masami Inoue, Naoyuki Uchida, Yasushi Onishi, Reiko Kamata, Mika Kotaki, Ryoji Kobayashi, et al. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program. Transplantation and cellular therapy. 2022. 28. 10. 677.e1-677.e6
-
Takeshi Sugio, Shingo Baba, Yasuo Mori, Goichi Yoshimoto, Kenjiro Kamesaki, Shuichiro Takashima, Shingo Urata, Takahiro Shima, Kohta Miyawaki, Yoshikane Kikushige, et al. Prognostic value of pre-transplantation total metabolic tumor volume on 18fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography in relapsed and refractory aggressive lymphoma. International journal of hematology. 2022
more...
Return to Previous Page